Bausch & Lomb shares upgraded, price target raised - Investing.com

Oct 15, 2024  · On Tuesday, Bausch & Lomb Corp. (NYSE:BLCO) received an upgrade in its stock rating by Evercore ISI from In Line to Outperform, accompanied by a significant increase …


$25
OFF

Bausch & Lomb Shares Upgraded, Price Target Raised

2 weeks from now

Oct 15, 2024  · The anticipated deal for Bausch & Lomb could value the company at up to $25 per share, which would translate to an enterprise value (EV) of approximately $13.1 billion. This …

investing.com

$19.00
OFF

RBC Raises Bausch & Lomb Stock Price Target Ahead Of Q3 Results

2 weeks from now

Oct 22, 2024  · In terms of financial assessments, Evercore ISI upgraded Bausch & Lomb's stock rating from In Line to Outperform, raising its price target from $19.00 to $25.00.

investing.com

$18.00
OFF

Bausch & Lomb Shares Upgraded To Overweight By Morgan Stanley

2 weeks from now

May 6, 2024  · Accompanying this upgrade, the firm also raised the price target for the company's shares to $18.00 from the previous $16.00. Morgan Stanley's decision is based on the …

investing.com

$19.00
OFF

RBC Raises Bausch & Lomb Stock Price Target Ahead Of Q3 Results

2 weeks from now

Oct 22, 2024  · In terms of financial assessments, Evercore ISI upgraded Bausch & Lomb's stock rating from In Line to Outperform, raising its price target from $19.00 to $25.00. Stifel also …

investing.com

$23.00
OFF

Bausch & Lomb Stock Target Lifted, Keeps Buy On Strong Q3 Results

2 weeks from now

Oct 31, 2024  · On Thursday, H.C. Wainwright adjusted the stock price target for Bausch & Lomb Corp. (NYSE:BLCO) to $23.00, up from the previous target of $22.00, while maintaining a Buy …

investing.com

62%
OFF

Bausch + Lomb (BLCO) Price Target Increased By 7.62% To 22.25

2 weeks from now

The average one-year price target for Bausch + Lomb (NYSE:BLCO) has been revised to 22.25 / share. This is an increase of 7.62% from the prior estimate of 20.68 dated November 26, 2023.

nasdaq.com

$23
OFF

Bausch + Lomb’s Strong Financial Performance And Strategic …

2 weeks from now

Oct 31, 2024  · Bausch + Lomb price target raised to $23 from $22 at H.C. Wainwright Bausch + Lomb Sees Strong Growth in Q3 2024 Bausch + Lomb reports Q3 adjusted EPS 17c, …

businessinsider.com

$21.19
OFF

Bausch + Lomb Stock Hits 52-week High At $21.19 Amid Robust …

2 weeks from now

Oct 14, 2024  · Bausch + Lomb Corporation (BLCO) shares soared to a 52-week high of $21.19, reflecting a significant uptick in investor confidence. ... Stifel raised Bausch & Lomb's price …

investing.com

$23
OFF

Bausch + Lomb Price Target Raised To $23 From $22 At H.C.

2 weeks from now

Oct 31, 2024  · H.C. Wainwright analyst Yi Chen raised the firm’s price target on Bausch + Lomb (BLCO) to $23 from $22 and keeps a Buy rating on the share...

businessinsider.com

$26
OFF

Bausch + Lomb Price Target Raised To $26 From $23 At Wells Fargo

2 weeks from now

Oct 31, 2024  · Bausch + Lomb reports Q3 adjusted EPS 17c, consensus 22c Bausch + Lomb raises FY24 revenue view to $4.73B-$4.83B from $4.7B-$4.8B Bausch Health price target …

businessinsider.com

$630
OFF

Bausch + Lomb Prices IPO Below Target Range, Raises $630 Mln

2 weeks from now

May 6, 2022  · B y Echo Wang. NEW YORK, May 5 (Reuters) - Eye-care company Bausch + Lomb Corp on Thursday priced its initial public offering (IPO) well below its target range and …

nasdaq.com

$0.07
OFF

Bausch + Lomb Shares Climb On Earnings Beat, Raised Outlook

2 weeks from now

May 1, 2024  · The company's earnings per share (EPS) matched analyst expectations at $0.07. The positive financial results, coupled with an upgraded revenue outlook for the full year, have …

investing.com

$23.00
OFF

Bausch & Lomb Shares Retain Buy Rating, Steady Target Post …

2 weeks from now

Dec 12, 2024  · On Thursday, H.C. Wainwright reaffirmed its Buy rating and $23.00 stock price target for Bausch & Lomb Corporation (NYSE:BLCO), following the company's announcement …

investing.com

FAQs about Bausch & Lomb shares upgraded, price target raised - Investing.com Coupon?

Is Bausch & Lomb (BLCO) a good stock to buy?

RBC Capital analyst Douglas Miehm raised the firm’s price targeton Bausch + Lomb (BLCO) to $23 from $20 and keeps an Outperform rating on the shares ahead of its Q3 results. ...

What is the average price target for Bausch & Lomb?

The average price target represents an increase of 46.70% from the latest reported closing price of 15.17 / share. What is the Fund Sentiment? There are 124 funds or institutions reporting positions in Bausch + Lomb. ...

How many funds own Bausch & Lomb?

There are 124 funds or institutions reporting positions in Bausch + Lomb. This is an increase of 11 owner (s) or 9.73% in the last quarter. Average portfolio weight of all funds dedicated to BLCO is 0.51%, a decrease of 6.59%. Total shares owned by institutions increased in the last three months by 3.02% to 47,705K shares. ...

What is Bausch & Lomb?

Bausch & Lomb is a leading global eye health company dedicated to helping people see better to live better. Bausch + Lomb Corporation (NYSE/TSX: BLCO) ("Bausch + Lomb" or "the Company", "we" or "our") announced its third-quarter 2022 financial results. ...

Who bought Bausch & Lomb?

Valeant Pharmaceuticals, Canada's largest drugmaker, reported Monday that they will purchase eyecare product maker Bausch and Lomb from private equity firm Warburg Pincus for $8.7 billion. (Photo by Justin Sullivan/Getty Images) ...

Does Bausch + Lomb update their news releases?

Bausch + Lomb does not update, correct or revise news releases after they have been issued. For the most current information, please refer to the most recent news releases. Read messages from our CEO. ...

Install CouponFollow Extension on Chrome

Install the CouponFollow extension to search for discount codes when shopping the fastest!

Install CouponFollow Chrome Extension   Install CouponFollow Chrome Extension